Clinical Trial Update: Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients) [NA]

View source ↗

Summary

This document reports an update on the AIM-HIGH trial evaluating adjuvant chemotherapy in intermediate/high-risk stage I or stage IIA non-squamous non-small cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Razor Genomics | Conditions: Non-Small Cell Lung Cancer | NA | Status: ACTIVE_NOT_RECRUITING